The recommendations set out the principles of diagnosis and treatment of hepatitis C virus
(HCV) infections according to the most recent knowledge. The main goal of therapy for HCV …

Background: Prior to direct-acting antiviral (DAA) therapy, personalised medicine played an
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …

The goals of treatment is to eliminate HCV infection, stop or reverse histological changes,
reduce the risk of hepatocellular carcinoma development and transmission of the infection to …

The aim of the EpiTer‐2 study was to analyse patient characteristics and their medication for
HCV infection in Poland at the beginning of the interferon‐free era. Analysis of data of HCV …

Results The study population was sex-balanced with a small predominance of women, who
were older than men. We observed reduction of age between the first and third time interval …

We followed for 2 years patients treated with direct‐acting agents (DAA) to assess long‐term
durability of virologic response, improvement of liver function, reduction in liver stiffness (LS) …

Despite the lack of precise mechanisms of action, a growing number of studies suggests that
gut microbiota is involved in a great number of physiological functions of the human …

BACKGROUND The treatment of hepatitis C with direct-acting antiviral agents (DAAs)
produces a high rate of sustained virological response (SVR) with fewer adverse events …

Background: Chronic hepatitis C is a major public health problem around the world. In
monitoring treatment efficacy, although costly and labour-intensive methods of molecular …

Results The current diagnosis rate in Poland was calculated as 31%. The scenario without
intervention resulted in gradual reduction of annual treatments accompanied by a decrease …